Canada Markets closed

Columbia Care Inc. (CCHWF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.7315+0.0207 (+2.91%)
At close: 03:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.7108
Open0.6986
BidN/A x N/A
AskN/A x N/A
Day's Range0.6900 - 0.7400
52 Week Range0.6000 - 3.3900
Volume184,726
Avg. Volume575,345
Market Cap319.116M
Beta (5Y Monthly)1.86
PE Ratio (TTM)N/A
EPS (TTM)-0.3930
Earnings DateMar 22, 2023 - Mar 27, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.62
  • Business Wire

    Columbia Care Opens New Cannabist in Hampton, Virginia

    NEW YORK, January 31, 2023--Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) ("Columbia Care" or the "Company"), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced it has opened its newest Cannabist dispensary in Hampton, Virginia, located at 2400 Cunningham Drive, Suite 600. The location is the Company’s 83rd active dispensary and the 34th Cannabist location in the U.S.

  • Business Wire

    Columbia Care Implements Efficiency Initiatives to Enhance Profitability

    NEW YORK, January 19, 2023--Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) ("Columbia Care" or the "Company"), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today that it has undertaken a number of initiatives to increase efficiency, decrease expenses and transition to cash flow positive in order to further strengthen its operations and financial performance. The Company closed four unprofitable

  • Market Exclusive

    Weekly Roundup on the Cannabis Sector & Psychedelic Sector

    Key Takeaways; Cannabis Sector Columbia Care released its first report on corporate social responsibility. Curaleaf expanded “The Farmer’s Select” collaboration with Autumn Brands. Key Takeaways; Psychedelic Sector Awakn saw significant gains after recording impressive revenue growth in Q3 2022; The company also announced a Phase III clinical trial for its ketamine-assisted therapy. Revive announced expansion […] The post Weekly Roundup on the Cannabis Sector & Psychedelic Sector appeared first